➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Baxter
Boehringer Ingelheim
Colorcon
Moodys

Last Updated: June 24, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for GS-9857


Email this page to a colleague

« Back to Dashboard

What is the drug development status for GS-9857?

GS-9857 is an investigational drug.

There have been 15 clinical trials for GS-9857. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2015.

The most common disease conditions in clinical trials are Hepatitis C, Infection, and Virus Diseases. The leading clinical trial sponsors are Gilead Sciences, Unity Health Care, Inc., and University of Maryland.

There are twenty-nine US patents protecting this investigational drug and seven hundred and forty-six international patents.

Recent Clinical Trials for GS-9857
TitleSponsorPhase
Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV InfectionGilead SciencesPhase 3
Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment StudyGilead SciencesPhase 3
Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Subjects With Previous DAA ExperienceGilead SciencesPhase 2

See all GS-9857 clinical trials

Clinical Trial Summary for GS-9857

Top disease conditions for GS-9857
Top clinical trial sponsors for GS-9857

See all GS-9857 clinical trials

US Patents for GS-9857

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
GS-9857   Try Before You Buy Synthesis of an antiviral compound GILEAD SCIENCES, INC. (Foster City, CA)   Try Before You Buy
GS-9857   Try Before You Buy Combination formulation of two antiviral compounds Gilead Pharmasset LLC (Foster City, CA)   Try Before You Buy
GS-9857   Try Before You Buy Toll like receptor modulator compounds GILEAD SCIENCES, INC. (Foster City, CA)   Try Before You Buy
GS-9857   Try Before You Buy Inhibitors of hepatitis C virus Gilead Pharmasset LLC (Foster City, CA)   Try Before You Buy
GS-9857   Try Before You Buy Toll like receptor modulator compounds GILEAD SCIENCES, INC. (Foster City, CA)   Try Before You Buy
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for GS-9857

Drugname Country Document Number Estimated Expiration Related US Patent
GS-9857 Argentina AR098959 2033-12-23   Try Before You Buy
GS-9857 Australia AU2014370125 2033-12-23   Try Before You Buy
GS-9857 Canada CA2934537 2033-12-23   Try Before You Buy
GS-9857 China CN105849118 2033-12-23   Try Before You Buy
GS-9857 China CN111320610 2033-12-23   Try Before You Buy
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Boehringer Ingelheim
Colorcon
McKinsey
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.